EMEA-002213-PIP01-17 - paediatric investigation plan
Sirolimus
PIPHuman
Vascular Therapies, Inc.
Tel. +1 2012668310
E-mail: david@vasculartx.com
P/0395/2017: EMA decision of 19 December 2017 on the granting of a product specific waiver for sirolimus (EMEA-002213-PIP01-17)